TCL Archive NCI Get Go-Ahead For New Cancer Control Projects Totaling $7.4 Million, Funded By Grants, Contracts October 21, 1977
TCL Archive Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase December 31, 2010
TCL Archive Phase III Trial Shows Benefit For Old Drugs, Old Device, For Ovarian Cancer, But Will Practice Change? January 20, 2006
TCL Archive In Brief: ASTRO Officers Named; AACR Fellowships Available; NRC Won’t Revoke NIH License November 10, 1995